{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:36:09Z","timestamp":1761561369936,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.sapharm.2009.06.004","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T04:32:19Z","timestamp":1253593939000},"page":"482-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescribing trends for management of congestive heart failure from 2002 to 2004"],"prefix":"10.1016","volume":"9","author":[{"given":"Tonya","family":"Crawford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry W.","family":"Segars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafia S.","family":"Rasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.sapharm.2009.06.004_bib1","first-page":"e21","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2009.06.004_bib2","first-page":"e25","article-title":"Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.sapharm.2009.06.004_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2009.06.004_bib4","first-page":"693","article-title":"The economic burden of congestive heart failure in a managed care population","volume":"6","author":"Xuan","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2009.06.004_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1071-9164(95)90021-7","article-title":"Heart failure: evaluation and care of patients with left ventricular systolic dysfunction","volume":"1","author":"Konstam","year":"1995","journal-title":"J Card Fail"},{"issue":"14","key":"10.1016\/j.sapharm.2009.06.004_bib6","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2165\/00003495-200161140-00002","article-title":"Underutilisation of ACE inhibitors in patients with\u00a0congestive heart failure","volume":"61","author":"Bungard","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.sapharm.2009.06.004_bib7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0002-9149(97)89177-1","article-title":"Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals","volume":"77","author":"Philbin","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sapharm.2009.06.004_bib8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2009.06.004_bib9","first-page":"1","article-title":"National Ambulatory Medical Care Survey: 2006 summary","author":"Cherry","year":"2008","journal-title":"Natl Health Stat Rep"},{"author":"Ambulatory Health Care Data","key":"10.1016\/j.sapharm.2009.06.004_bib10"},{"key":"10.1016\/j.sapharm.2009.06.004_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/clc.4960210208","article-title":"Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting","volume":"21","author":"Philbin","year":"1998","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.sapharm.2009.06.004_bib12","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1001\/archinte.1997.00440420092008","article-title":"National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure","volume":"157","author":"Stafford","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2009.06.004_bib13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archinte.158.10.1074","article-title":"Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995","volume":"158","author":"Smith","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2009.06.004_bib14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.amjcard.2009.01.363","article-title":"Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease","volume":"103","author":"Allen LaPointe","year":"2009","journal-title":"Am J\u00a0Cardiol"},{"key":"10.1016\/j.sapharm.2009.06.004_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjcard.2007.08.050","article-title":"Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients \u226565 years of age with heart failure and preserved left ventricular systolic function","volume":"101","author":"Shah","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sapharm.2009.06.004_bib16","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2009.06.004_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart\u00a0Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.sapharm.2009.06.004_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000093612","article-title":"Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE","volume":"107","author":"Peacock","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.sapharm.2009.06.004_bib19","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","author":"Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)","year":"2002","journal-title":"JAMA"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741109000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741109000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:07:29Z","timestamp":1761556049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741109000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1551741109000758"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2009.06.004","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing trends for management of congestive heart failure from 2002 to 2004","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2009.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}